Therapeutic Use of Diaminophenothiazines

WO2009044127

Claude Michel Wischik (Inventor), Wischik Damon J. (Inventor), John Mervyn David Storey (Inventor), Charles Robert Harrington (Inventor)

Research output: Patent

2 Downloads (Pure)

Abstract

C.M.Wischik, D.J. Wischik, J.M.D.Storey, C.R.Harrington
The present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.
Original languageEnglish
IPCWO2009/044127
Publication statusPublished - 9 Apr 2009

Fingerprint

Dosage Forms
Therapeutic Uses
Pharmacokinetics

Cite this

@misc{e38df67628514cecb5fc808f9222c572,
title = "Therapeutic Use of Diaminophenothiazines: WO2009044127",
abstract = "C.M.Wischik, D.J. Wischik, J.M.D.Storey, C.R.HarringtonThe present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.",
author = "Wischik, {Claude Michel} and {Damon J.}, Wischik and Storey, {John Mervyn David} and Harrington, {Charles Robert}",
year = "2009",
month = "4",
day = "9",
language = "English",
type = "Patent",
note = "WO2009/044127",

}

TY - PAT

T1 - Therapeutic Use of Diaminophenothiazines

T2 - WO2009044127

AU - Wischik, Claude Michel

AU - Damon J., Wischik

AU - Storey, John Mervyn David

AU - Harrington, Charles Robert

PY - 2009/4/9

Y1 - 2009/4/9

N2 - C.M.Wischik, D.J. Wischik, J.M.D.Storey, C.R.HarringtonThe present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.

AB - C.M.Wischik, D.J. Wischik, J.M.D.Storey, C.R.HarringtonThe present invention relates generally to methods and materials for use in the treatment or prophylaxis of diseases, for example cognitive disorders, using diaminophenothiazines. In particular it relates to treatments having optimised pharmacokinetic properties, and dosage forms are intended to improve the relative cognitive or CNS benefits of the diaminophenothiazines, for instance compared to haematological effects.

M3 - Patent

ER -